Press release
Research News: Global AI-based Clinical Trial Solution Market Size Analysis 2020 due to COVID-19 Impact
This report also researches and evaluates the impact of Covid-19 outbreak on the AI-based Clinical Trial Solution industry, involving potential opportunity and challenges, drivers and risks. We present the impact assessment of Covid-19 effects on AI-based Clinical Trial Solution and market growth forecast based on different scenario (optimistic, pessimistic, very optimistic, most likely etc.).GLOBAL INFO RESEARCH added a new research report to its exhaustive repository. The research report, titled [Global AI-based Clinical Trial Solution Market 2020 by Company, Regions, Type and Application, Forecast to 2025], presents an unbiased approach at understanding the market trends and dynamics. Analysts have studied the historical data pertaining to the market and compared it to the current market trends to paint an object picture of the market’s trajectory. The report includes SWOT analysis and Porter’s five forces analysis to give the readers an in-depth assessment of the various factors likely to drive and restrain the overall market.
Both the market measurement tools offer evaluation of the strengths, weaknesses, opportunities, and threats. It also elucidates the bargaining power of suppliers and buyers. The report studies the ongoing political scenarios that are expected to dictate the pricing and import and export in the global AI-based Clinical Trial Solution market. Furthermore, it also explains the lucrative opportunities present in the overall market that players can focus on to make their mark.
Click to view the full report TOC, figure and tables: https://www.globalinforesearch.com/Global-AI-based-Clinical-Trial-Solution_p502346.html
The following Companies as the Key Players in the Global AI-based Clinical Trial Solution Market Research Report:
AiCure
Median Technologies
Saama Technologies
Antidote
Innoplexus
Deep Lens
Phesi
Deep 6 AI
Trials.ai
Mendel.ai
Deloitte
Innoplexus
IBM
Regions Covered in the Global AI-based Clinical Trial Solution Market:
The Middle East and Africa (GCC Countries and Egypt)
North America (the United States, Mexico, and Canada)
South America (Brazil etc.)
Europe (Turkey, Germany, Russia UK, Italy, France, etc.)
Asia-Pacific (Vietnam, China, Malaysia, Japan, Philippines, Korea, Thailand, India, Indonesia, and Australia)
The scope of the Report:
The research report on AI-based Clinical Trial Solution includes segmentation of the market. The global AI-based Clinical Trial Solution market is segmented on the basis of application, services, end users, and region. Each segment includes a detailed explanation of the factors that are likely to drive and restrain it. In addition, the research report also provides an assessment of the emerging trends in the global market that will benefit each segment during the forecast years.
Analysts have also studied the competitive landscape present in the global AI-based Clinical Trial Solution market. The chapter on company profiles includes an analysis of the key players operating in the global AI-based Clinical Trial Solution market. It provides vital information about the strategic initiatives about the companies in the market and their outlook for the forecast years.
Strategic Points Covered in TOC:
Chapter 1: Introduction, market driving force product scope, market risk, market overview, and market opportunities of the global AI-based Clinical Trial Solution market
Chapter 2: Evaluating the leading manufacturers of the global AI-based Clinical Trial Solution market which consists of its revenue, sales, and price of the products
Chapter 3: Displaying the competitive nature among key manufacturers, with market share, revenue, and sales
Chapter 4: Presenting global AI-based Clinical Trial Solution market by regions, market share and with revenue and sales for the projected period
Chapter 5, 6, 7, 8 and 9: To evaluate the market by segments, by countries and by manufacturers with revenue share and sales by key countries in these various regions
Table of Content
1 AI-based Clinical Trial Solution Market Overview
1.1 Product Overview and Scope of AI-based Clinical Trial Solution
1.2 Classification of AI-based Clinical Trial Solution by Type
1.2.1 Global AI-based Clinical Trial Solution Revenue by Type: 2015 VS 2019 VS 2025
1.2.2 Global AI-based Clinical Trial Solution Revenue Market Share by Type in 2019
1.2.3 Artificial Narrow Intelligence
1.2.4 Artificial General Intelligence
1.2.5 Artificial Super Intelligence
1.3 Global AI-based Clinical Trial Solution Market by Application
1.3.1 Overview: Global AI-based Clinical Trial Solution Revenue by Application: 2015 VS 2019 VS 2025
1.3.2 Drug Discovery
1.3.3 Drug Manufacturing
1.3.4 Drug Marketing
1.3.5 Diagnosis and Treatment
1.3.6 Clinical Trials
1.4 Global AI-based Clinical Trial Solution Market by Regions
1.4.1 Global AI-based Clinical Trial Solution Market Size by Regions: 2015 VS 2019 VS 2025
1.4.2 Global Market Size of AI-based Clinical Trial Solution (2015-2025)
1.4.3 North America (USA, Canada and Mexico) AI-based Clinical Trial Solution Status and Prospect (2015-2025)
1.4.4 Europe (Germany, France, UK, Russia and Italy) AI-based Clinical Trial Solution Status and Prospect (2015-2025)
1.4.5 Asia-Pacific (China, Japan, Korea, India and Southeast Asia) AI-based Clinical Trial Solution Status and Prospect (2015-2025)
1.4.6 South America (Brazil, Argentina, Colombia) AI-based Clinical Trial Solution Status and Prospect (2015-2025)
1.4.7 Middle East & Africa (Saudi Arabia, UAE, Egypt, Nigeria and South Africa) AI-based Clinical Trial Solution Status and Prospect (2015-2025)
2 Company Profiles
2.1 AiCure
2.1.1 AiCure Details
2.1.2 AiCure Major Business
2.1.3 AiCure SWOT Analysis
2.1.4 AiCure Product and Services
2.1.5 AiCure AI-based Clinical Trial Solution Revenue, Gross Margin and Market Share (2018-2019)
2.2 Median Technologies
2.2.1 Median Technologies Details
2.2.2 Median Technologies Major Business
2.2.3 Median Technologies SWOT Analysis
2.2.4 Median Technologies Product and Services
2.2.5 Median Technologies AI-based Clinical Trial Solution Revenue, Gross Margin and Market Share (2018-2019)
2.3 Saama Technologies
2.3.1 Saama Technologies Details
2.3.2 Saama Technologies Major Business
2.3.3 Saama Technologies SWOT Analysis
2.3.4 Saama Technologies Product and Services
2.3.5 Saama Technologies AI-based Clinical Trial Solution Revenue, Gross Margin and Market Share (2018-2019)
2.4 Antidote
2.4.1 Antidote Details
2.4.2 Antidote Major Business
2.4.3 Antidote SWOT Analysis
2.4.4 Antidote Product and Services
2.4.5 Antidote AI-based Clinical Trial Solution Revenue, Gross Margin and Market Share (2018-2019)
2.5 Innoplexus
2.5.1 Innoplexus Details
2.5.2 Innoplexus Major Business
2.5.3 Innoplexus SWOT Analysis
2.5.4 Innoplexus Product and Services
2.5.5 Innoplexus AI-based Clinical Trial Solution Revenue, Gross Margin and Market Share (2018-2019)
2.6 Deep Lens
2.6.1 Deep Lens Details
2.6.2 Deep Lens Major Business
2.6.3 Deep Lens Product and Services
2.6.4 Deep Lens AI-based Clinical Trial Solution Revenue, Gross Margin and Market Share (2018-2019)
2.7 Phesi
2.7.1 Phesi Details
2.7.2 Phesi Major Business
2.7.3 Phesi Product and Services
2.7.4 Phesi AI-based Clinical Trial Solution Revenue, Gross Margin and Market Share (2018-2019)
2.8 Deep 6 AI
2.8.1 Deep 6 AI Details
2.8.2 Deep 6 AI Major Business
2.8.3 Deep 6 AI Product and Services
2.8.4 Deep 6 AI AI-based Clinical Trial Solution Revenue, Gross Margin and Market Share (2018-2019)
2.9 Trials.ai
2.9.1 Trials.ai Details
2.9.2 Trials.ai Major Business
2.9.3 Trials.ai Product and Services
2.9.4 Trials.ai AI-based Clinical Trial Solution Revenue, Gross Margin and Market Share (2018-2019)
2.10 Mendel.ai
2.10.1 Mendel.ai Details
2.10.2 Mendel.ai Major Business
2.10.3 Mendel.ai Product and Services
2.10.4 Mendel.ai AI-based Clinical Trial Solution Revenue, Gross Margin and Market Share (2018-2019)
2.11 Deloitte
2.11.1 Deloitte Details
2.11.2 Deloitte Major Business
2.11.3 Deloitte Product and Services
2.11.4 Deloitte AI-based Clinical Trial Solution Revenue, Gross Margin and Market Share (2018-2019)
2.12 Innoplexus
2.12.1 Innoplexus Details
2.12.2 Innoplexus Major Business
2.12.3 Innoplexus Product and Services
2.12.4 Innoplexus AI-based Clinical Trial Solution Revenue, Gross Margin and Market Share (2018-2019)
2.13 IBM
2.13.1 IBM Details
2.13.2 IBM Major Business
2.13.3 IBM Product and Services
2.13.4 IBM AI-based Clinical Trial Solution Revenue, Gross Margin and Market Share (2018-2019)
3 Market Competition, by Players
3.1 Global AI-based Clinical Trial Solution Revenue and Share by Players (2015-2020)
3.2 Market Concentration Rate
3.2.1 Top 5 AI-based Clinical Trial Solution Players Market Share
3.2.2 Top 10 AI-based Clinical Trial Solution Players Market Share
3.3 Market Competition Trend
4 Market Size by Regions
4.1 Global AI-based Clinical Trial Solution Revenue and Market Share by Regions
4.2 North America AI-based Clinical Trial Solution Revenue and Growth Rate (2015-2020)
4.3 Europe AI-based Clinical Trial Solution Revenue and Growth Rate (2015-2020)
4.4 Asia-Pacific AI-based Clinical Trial Solution Revenue and Growth Rate (2015-2020)
4.5 South America AI-based Clinical Trial Solution Revenue and Growth Rate (2015-2020)
4.6 Middle East & Africa AI-based Clinical Trial Solution Revenue and Growth Rate (2015-2020)
5 North America AI-based Clinical Trial Solution Revenue by Countries
5.1 North America AI-based Clinical Trial Solution Revenue by Countries (2015-2020)
5.2 USA AI-based Clinical Trial Solution Revenue and Growth Rate (2015-2020)
5.3 Canada AI-based Clinical Trial Solution Revenue and Growth Rate (2015-2020)
5.4 Mexico AI-based Clinical Trial Solution Revenue and Growth Rate (2015-2020)
6 Europe AI-based Clinical Trial Solution Revenue by Countries
6.1 Europe AI-based Clinical Trial Solution Revenue by Countries (2015-2020)
6.2 Germany AI-based Clinical Trial Solution Revenue and Growth Rate (2015-2020)
6.3 UK AI-based Clinical Trial Solution Revenue and Growth Rate (2015-2020)
6.4 France AI-based Clinical Trial Solution Revenue and Growth Rate (2015-2020)
6.5 Russia AI-based Clinical Trial Solution Revenue and Growth Rate (2015-2020)
6.6 Italy AI-based Clinical Trial Solution Revenue and Growth Rate (2015-2020)
7 Asia-Pacific AI-based Clinical Trial Solution Revenue by Regions
7.1 Asia-Pacific AI-based Clinical Trial Solution Revenue by Regions (2015-2020)
7.2 China AI-based Clinical Trial Solution Revenue and Growth Rate (2015-2020)
7.3 Japan AI-based Clinical Trial Solution Revenue and Growth Rate (2015-2020)
7.4 Korea AI-based Clinical Trial Solution Revenue and Growth Rate (2015-2020)
7.5 India AI-based Clinical Trial Solution Revenue and Growth Rate (2015-2020)
7.6 Southeast Asia AI-based Clinical Trial Solution Revenue and Growth Rate (2015-2020)
8 South America AI-based Clinical Trial Solution Revenue by Countries
8.1 South America AI-based Clinical Trial Solution Revenue by Countries (2015-2020)
8.2 Brazil AI-based Clinical Trial Solution Revenue and Growth Rate (2015-2020)
8.3 Argentina AI-based Clinical Trial Solution Revenue and Growth Rate (2015-2020)
9 Middle East & Africa Revenue AI-based Clinical Trial Solution by Countries
9.1 Middle East & Africa AI-based Clinical Trial Solution Revenue by Countries (2015-2020)
9.2 Saudi Arabia AI-based Clinical Trial Solution Revenue and Growth Rate (2015-2020)
9.3 UAE AI-based Clinical Trial Solution Revenue and Growth Rate (2015-2020)
9.4 Egypt AI-based Clinical Trial Solution Revenue and Growth Rate (2015-2020)
9.5 South Africa AI-based Clinical Trial Solution Revenue and Growth Rate (2015-2020)
10 Market Size Segment by Type
10.1 Global AI-based Clinical Trial Solution Revenue and Market Share by Type (2015-2020)
10.2 Global AI-based Clinical Trial Solution Market Forecast by Type (2019-2024)
10.3 Artificial Narrow Intelligence Revenue Growth Rate (2015-2025)
10.4 Artificial General Intelligence Revenue Growth Rate (2015-2025)
10.5 Artificial Super Intelligence Revenue Growth Rate (2015-2025)
11 Global AI-based Clinical Trial Solution Market Segment by Application
11.1 Global AI-based Clinical Trial Solution Revenue Market Share by Application (2015-2020)
11.2 AI-based Clinical Trial Solution Market Forecast by Application (2019-2024)
11.3 Drug Discovery Revenue Growth (2015-2020)
11.4 Drug Manufacturing Revenue Growth (2015-2020)
11.5 Drug Marketing Revenue Growth (2015-2020)
11.6 Diagnosis and Treatment Revenue Growth (2015-2020)
11.7 Clinical Trials Revenue Growth (2015-2020)
12 Global AI-based Clinical Trial Solution Market Size Forecast (2021-2025)
12.1 Global AI-based Clinical Trial Solution Market Size Forecast (2021-2025)
12.2 Global AI-based Clinical Trial Solution Market Forecast by Regions (2021-2025)
12.3 North America AI-based Clinical Trial Solution Revenue Market Forecast (2021-2025)
12.4 Europe AI-based Clinical Trial Solution Revenue Market Forecast (2021-2025)
12.5 Asia-Pacific AI-based Clinical Trial Solution Revenue Market Forecast (2021-2025)
12.6 South America AI-based Clinical Trial Solution Revenue Market Forecast (2021-2025)
12.7 Middle East & Africa AI-based Clinical Trial Solution Revenue Market Forecast (2021-2025)
13 Research Findings and Conclusion
14 Appendix
14.1 Methodology
14.2 Data Source
14.3 Disclaimer
14.4 About US
About Us:
GlobaI Info Research(GIR) is a report publisher, a customer, interest-based suppliers. Is in the best interests of our clients, they determine our every move. At the same time, we have great respect for the views of customers. With the improvement of the quality of our research, we develop custom interdisciplinary and comprehensive solution. For further development, we will do better and better. GlobalInfoResearch will with excellent professional knowledge and experience to carry out all aspects of our business. At the same time, we will thoroughly look for information, to give a more comprehensive development.
Contact US
Global Info Research
E-mail: report@globalinforesearch.com
Tel: +86-13660489451 00852-58197708(HK)
Add:FLAT/RM A 9/F SILVERCORP INTERNATIONAL TOWER 707-713 NATHAN ROAD MONGKOK KL HONG KONG
Website: http://www.globalinforesearch.com
Contact US
Global Info Research
E-mail: report@globalinforesearch.com
Tel: +86-13660489451 00852-58197708(HK)
Add:FLAT/RM A 9/F SILVERCORP INTERNATIONAL TOWER 707-713 NATHAN ROAD MONGKOK KL HONG KONG
Website: http://www.globalinforesearch.com
GlobaI Info Research(GIR) is a report publisher, a customer, interest-based suppliers. Is in the best interests of our clients, they determine our every move. At the same time, we have great respect for the views of customers. With the improvement of the quality of our research, we develop custom interdisciplinary and comprehensive solution. For further development, we will do better and better. GlobalInfoResearch will with excellent professional knowledge and experience to carry out all aspects of our business. At the same time, we will thoroughly look for information, to give a more comprehensive development.
This release was published on openPR.
Permanent link to this press release:
Copy
Please set a link in the press area of your homepage to this press release on openPR. openPR disclaims liability for any content contained in this release.
You can edit or delete your press release Research News: Global AI-based Clinical Trial Solution Market Size Analysis 2020 due to COVID-19 Impact here
News-ID: 2154511 • Views: …
More Releases from GLOBAL INFO RESEARCH

Global Long Chain Dicarboxylic Acid Market Growth Forecast Report 2025-2031
On Sep 5, the latest report "Global Long Chain Dicarboxylic Acid Market 2025 by Manufacturers, Regions, Types and Applications, Forecast to 2031" from Global Info Research provides a detailed and comprehensive analysis of the global Long Chain Dicarboxylic Acid market. The report provides both quantitative and qualitative analysis by manufacturers, regions and countries, types and applications. As the market is constantly changing, this report explores market competition, supply and demand…

Low Density Polyethylene (LDPE) Latest Market Analysis Report 2025
On Sep 5, 2025, Global Info Research released a research report titled "Global Low Density Polyethylene (LDPE) Market 2025 by Manufacturers, Regions, Type and Application, Forecast to 2031". This report provides detailed data analysis of the Low Density Polyethylene (LDPE) market from 2020 to 2031. Including the market size and development trends of Low Density Polyethylene (LDPE) Market, it analyzes market size indicators such as sales, sales volume,…

Lubricant Viscosity Grade Improvers Market Share, Revenue, Price, Growth Rate Ra …
Global Info Research's report offers key insights into the recent developments in the global Lubricant Viscosity Grade Improvers market that would help strategic decisions. It also provides a complete analysis of the market size, share, and potential growth prospects. Additionally, an overview of recent major trends, technological advancements, and innovations within the market are also included. Our report further provides readers with comprehensive insights and actionable analysis on the…

Global Mining Flotation Chemicals Market Competitor Analysis Report 2025
On Sep 5, 2025, Global Info Research released a research report titled "Global Mining Flotation Chemicals Market 2025 by Manufacturers, Regions, Type and Application, Forecast to 2031". This report provides detailed data analysis of the Mining Flotation Chemicals market from 2020 to 2031. Including the market size and development trends of Mining Flotation Chemicals Market, it analyzes market size indicators such as sales, sales volume, average price and…
More Releases for Trial
Transformative Trends Impacting the Electronic Trial Master File (eTMF) Systems …
Use code ONLINE30 to get 30% off on global market reports and stay ahead of tariff changes, macro trends, and global economic shifts.
How Large Will the Electronic Trial Master File (eTMF) Systems Market Size By 2025?
The market size of the electronic trial master file (eTMF) systems has experienced fast growth over recent years. The market is projected to increase from $1.36 billion in 2024 to $1.55 billion in 2025, with…
Transformative Trends Impacting the Electronic Trial Master File (eTMF) Systems …
Use code ONLINE30 to get 30% off on global market reports and stay ahead of tariff changes, macro trends, and global economic shifts.
How Large Will the Electronic Trial Master File (eTMF) Systems Market Size By 2025?
The market size of the electronic trial master file (eTMF) systems has experienced fast growth over recent years. The market is projected to increase from $1.36 billion in 2024 to $1.55 billion in 2025, with…
Clinical Trial Imaging market
The Clinical Trial Imaging market crossed the US$ 1.09 billion mark in 2022 and is expected to hit US$ 1.94 billion by 2030, recording a CAGR of 7.5% during the forecast period.
Rising R&D spending, a rapidly growing pharmaceutical industry, and an increase in the number of contract research organizations are some of the major factors driving the market's growth. There has been an increase in pharmaceutical companies due to the…
Clinical Trial Management System
According to a new market report published by Persistence Market Research “Global Market Study on Clinical Trial Management System: Asia to Witness Highest Growth by 2019” the global clinical trial management system market was valued at USD 844.0 million in 2013 and is expected to grow at a CAGR of 14% from 2014 to 2019, to reach an estimated value of USD 1,848.5 million in 2019.
Request Report TOC @ https://www.persistencemarketresearch.com/methodology/3017
…
Clinical Trial Logistics
Clinical Trial Logistics
16th to 17th May 2011, Marriott Regents Park, London, United Kingdom.
It currently costs just over £500 million ($800 million) to bring a new chemical to market and development timelines continue to fall in the 10-15 year range. A key reason for high R&D costs is due to logistical failures including failure to recruit patients on time. A way to avoid this is to move clinical trials…
Clinical Trial Logistics
Announcing SMi's 5th annual…
Clinical Trial Logistics conference
16th and 17th May 2011, Central London, UK
www.smi-online.co.uk/2011logistics-london6.asp
It currently costs just over £500 million ($800 million) to bring a new chemical to market and development timelines continue to fall in the 10-15 year range. A key reason for high R&D costs is due to logistical failures including failure to recruit patients on time. A way to avoid this is to move clinical…